Sept 8: At the end of July, Citius Pharmaceuticals received a Complete Response Letter from the FDA pertaining to its Biologics License Application for Lymphir, an engineered IL-2-diphtheria toxin fusion protein intended to treat relapsed or refractory cutaneous T-cell lymphoma
Wound healing and post-procedure recovery GHK-Cus wound-healing properties are among its most extensively validated applications
Avoid trauma or injury to the skin
Thanks to the recycling process, both types of antioxidants are better able to keep working in the body to defend against free radicals. Safety and Considerations Most people can take astaxanthin and glutathione safely together
A PlexusDx provider conversation can integrate your genetic context, baseline biomarker results, clinical evidence for GHK-Cu, and your individual hair loss pattern to help determine whether GHK-Cu, nutritional optimization, or another approach may be more appropriate first
R.KwonM